Ginkgo Bioworks (DNA) Reports In-Line Q1 EPS, misses on revenue

Ginkgo Bioworks (NYSE: DNA) reported Q1 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $37.94 million versus the consensus estimate of $46.37 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• UBS Upgrades Nan Ya Plastics Corp. (1303:TT) to Buy
• Moody’s upgrades Cushman & Wakefield rating to Ba3 on debt reduction